| http://www.w3.org/ns/prov#value | - Vrouenraets Saskia M E SM IATEC, Pietersbergweg 9, 1105 BM Amsterdam, The Netherlands. - - 2007 Efavirenz is a non-nucleoside reverse transcriptase inhibitor that in most treatment guidelines is recommended to be taken combined with two nucleoside analogue reverse transcriptase inhibitors, as a preferred first-line regimen for the treatment of HIV-1 infection.
|
